Nephrology News & Issues Current Issue
The following articles appeared in the print edition of Nephrology News & Issues.
Table of Contents
- High mortality rate, impact of COVID-19 make AKI difficult to treat, manage Mark E. Neumann
-
- Assisted home dialysis found cost-effective for Canadian health care system Melissa J. Webb, MA
- Expert discusses AKI incidence, now on a ‘downward trend,’ in COVID-19 hospitalizations Melissa J. Webb, MA
- Fabry disease linked with increased mortality risk in transplant patients Maria Marabito
- FDA approves Korsuva as treatment for pruritus in patients on hemodialysis
- FDA: Ardelyx phosphorus control drug tenapanor lacks ‘clinical significance’ Mark E. Neumann
- Fluctuations in BMI linked to worse prognosis for patients with nondialysis-dependent CKD Melissa J. Webb, MA
- Initiative aims to eliminate preventable deaths from AKI worldwide by 2025 Mark E. Neumann
- Patients on dialysis develop SARS-CoV-2 antibodies that reduce likelihood of reinfection Melissa J. Webb, MA
-
- Patients on dialysis received no nutritional benefit from daily energy-dense supplements Melissa J. Webb, MA
- Renal community looks back, prepares for future in the treatment of AKI
- Speaker: Patient input critical for ensuring equitable access to new dialysis technologies Melissa J. Webb, MA
- Vaccine acceptance improves for patients on dialysis, but physician encouragement is key Melissa J. Webb, MA
- High caseloads in dialysis impact social determinants of health Beth Witten, MSW, ACSW, LSCSW; Teri Browne, PhD, MSW
- FDA approves Kerendia for the treatment of CKD, type 2 diabetes